Log in to your Inderes Free account to see all free content on this page.

BICO Group

19.88 SEK

+1.38 %

Less than 1K followers

BICO

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

+1.38 %

-16.82 %

-16.47 %

-46.12 %

-37.91 %

-35.66 %

-74.20 %

-90.23 %

+45.91 %

BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.

Market cap

1.4B SEK

Turnover

2.46M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

18.2.

2026

Annual report '25

29.4.

2026

Interim report Q1'26

7.5.

2026

General meeting '26

All

Webcasts

Press releases

ShowingAll content types

Press release11/14/2025, 11:34 AM

Redeye: BICO (Q3 Review) - A return to organic growth and adjusted EBITDA profitability

BICO, Audiocast, Q3'25

Webcast11/4/2025, 9:00 AM

BICO, Audiocast, Q3'25

Regulatory press release11/4/2025, 6:00 AM

Publication of BICO Group AB: Interim report Q3 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release11/3/2025, 5:01 PM

BICO provides preliminary figures for Q3 2025 and announces impairment

Press release10/21/2025, 5:00 AM

Invitation to the presentation of BICO’s Interim report Q3 2025

Regulatory press release10/10/2025, 5:00 AM

BICO Group AB’s Nomination Committee for the 2026 Annual General Meeting

Regulatory press release9/16/2025, 4:28 PM

Maria Rankka appointed Board Chair of BICO Group AB

Press release9/15/2025, 5:00 AM

Fraser McLeod appointed as Managing Director of BICO company Biosero

Regulatory press release9/4/2025, 10:05 PM

BICO company Biosero to develop integrated lab automation solutions to a value of 15.2 MUSD

Press release8/28/2025, 8:34 AM

Redeye: Redeye Initiates Coverage of BICO Group

BICO, Audiocast, Q2'25

Webcast8/19/2025, 8:00 AM

BICO, Audiocast, Q2'25

Regulatory press release8/19/2025, 5:00 AM

Publication of BICO Group AB Interim report January-June 2025

Press release8/18/2025, 4:00 PM

BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 98m

Press release8/5/2025, 5:00 AM

Invitation to the presentation of BICO’s Interim report Q2 2025

Press release7/1/2025, 3:30 PM

BICO has completed the divestment of MatTek and Visikol

Regulatory press release6/25/2025, 5:00 AM

Lars Risberg appointed as General Counsel for BICO Group AB

Regulatory press release5/23/2025, 5:00 AM

Chief Operating Officer Marius Balger is leaving BICO

Regulatory press release5/8/2025, 4:15 PM

Bulletin from Annual General Meeting in BICO Group AB (publ)

BICO, Audiocast with teleconference, Q1'25

Webcast4/29/2025, 8:00 AM

BICO, Audiocast with teleconference, Q1'25

Regulatory press release4/29/2025, 5:00 AM

Publication of BICO Group AB Interim report Q1 2025

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.